Browse products
Pharma Poland Online1 year subscription to internet service providing market news, analyses and analytical articles
|
View video about this product »
Our clients say...
“We use PMR's services due to their analysts' extensive experience in market analysis, their high quality and level of engagement in the market research carried out for us. We consider PMR a competent and professional company and recommend them as a reliable partner in the area of economic information and market analysis.”
Senior Trade and Investment Adviser, British Embassy in Warsaw
“PMR's analysts understand our needs well and the standard of their service has always fully met our expectations. We are looking forward to cooperating with PMR in the future as well. ”
Senior Trade and Investment Adviser, British Embassy in Warsaw
“As a London-based company, with operations abroad, we looked for the best-in-class Market Intelligence supplier. PMR brought us quality reports that improved our CEE market knowledge and understanding.”
Development Manager, GVA Grimley
“Sanofi-Aventis group regularly order PMR's reports and newsletters concerning the Polish pharmaceutical market. We use PMR's services because of the wealth of experience of its analysts in undertaking market analysis and a high level of quality and involvement in the field of market research. ”
General Manager, Sanofi-Synthelabo
“I am very satisfied with the service that PMR provides us. Our business needs up-to-date information as we would like to catch all the opportunities in our fast-growing markets. I receive all the important news about CEE and Russia from one source and gain insight from PMR markets analysis. I can recommend PMR as a partner to all companies who wish to make business on a professional level in this region.”
Development Director, Baltika Group
“It's a great pleasure to cooperate with PMR because of its analysts' wealth of experience in understanding the local market. We consider PMR a competent and professional company which helps us conduct our business. I would also like to state that PMR's team is always ready to respond to emerging customer needs. We can recommend it as a reliable partner.”
Business Analyst, Hilti Distribution, Russia
“We consider PMR a competent and professional company. PMR analysts understand our needs clearly and their services have fully met our expectations. I strongly recommend the company as a reliable partner in providing economic information and market analysis.”
General Manager, Sanofi-Synthelabo
“The information provided is very up-to-date and keeps us in the loop. Switching from pdf to online access proved to deliver even better results. We would always recommend PMR as a one-stop shop for all you need to know before making any decision. Thanks for all your efforts.
”
Development Manager, GVA Grimley
“I have been using PMR news update services for a few months and I appreciate their professionalism, kindliness of the staff, punctuality and quality of materials. I would strongly recommend the news update services as it is an economical way to save in-house company resources.”
Senior Analyst, Beragua Capital Advisory
“I really appreciate regularly receiving the most significant market information of our principal marketing area in a consolidated format. The PMR services include not only an accurate level of detail, but also have central instruments such as a subject index and an abstract for the conclusion, allowing a fast orientation.
”
Chief Marketing Officer, Eisberg Group
Brief description
All information is obtained and verified by PMR’s team of specialized editors and experienced analysts to ensure the utmost in accuracy.
This service is also available in pdf format newsletter - Pharma Poland News.
Compare PDF to online access.
Pharma Poland Online covers all the latest developments in:
- Market news – size, value, trends and forecasts for the complete market as well as each segment – prescription drugs, OTC, supplements, etc.
- Legislative and regulatory issues – news on changes affecting the marketplace – accompanied by commentary, opinion and interpretation
- Poland’s government healthcare policy – agency rules, drug reimbursement levels, alternative funding sources
- Poland’s reimbursement list – drug additions and eliminations, recommendations from AOTM, requirements for reimbursement
- Consumer preferences – treatment options, patient illnesses and care choices
- Company news – drug manufacturer and distributor activities including mergers & acquisitions, forecasts, new products, stock market activity, financial results, executive personnel changes, new pharmacy openings, strategies and investments
- R&D/ medical news – epidemiological data, public health policy, private healthcare market trends, forecasts and events, legal challenges, new facility openings, private and public investments, EU funding for modernization, healthcare personnel and hospital data for both public and private institutions, flu-related statistics
- Medical device sector – updates on new equipment development and availability for x-ray, scanner and similar equipment
- Coverage of major pharma market news in Bulgaria, Czech Republic, Hungary, Romania and Slovakia.
New! Database of mergers and acquisitions
The convenient online tool offers information about mergers and acquisitions on the pharmaceutical and medical market within Central and Eastern Europe and Poland.
The information contained in the database can be easily filtered according to the following variables: country (both the merging and the acquiring), date of completion, status of the transaction (incomplete – completed), value of the transaction, sector.
Articles, commentary, and interviews regarding key market issues
Pharma Poland Online includes 4-5 analytical articles each month that transcend regular news briefs to closely examine and analyze the leading trends, events, companies and regulations shaping the marketplace and clearing the pathways to success. Along with expert commentary and interviews with major market players, the unique content provided by PMR’s research and newsgathering staff focuses on current issues that are critical to industry success. Regular attendance at major conferences gives our staff access to discussions and presentations given by industry leaders, allowing our subscribers to benefit from proven solutions and coping strategies for a market distinguished by rapidly changing economic and regulatory conditions.
Popular topics include:
- Value of the pharmacy market, including drug prices and levels of profitability for various product categories
- Medication reimbursement list updates and analyses interpreting their effects on the market
- Legal analysis, prepared in conjunction with pharmaceutical law firms to clarify the implications of frequent regulatory changes upon market participants
- In depth exploration of developments in various segments of the Pharma Poland market, such as private healthcare, dentistry, clinical trials, dietary supplements, medical devices, and others
- Quarterly news and analyses of the regional pharmaceutical market of Central and Eastern Europe – covering Poland, Bulgaria, Czech Republic, Hungary, Romania and Slovakia
Subscribers keep current with monthly data updates on:
- Statistics related to the incidence of flu in Poland
- New drugs registered
- Drugs withdrawn and withheld from the market
- Relaunched drugs
- Drugs banned from advertising
Here’s a small example of the timely and informative content appearing in Pharma Poland Online:
- Abbot to introduce bioresorbable vascular scaffold to Polish market
- Reimbursement Act submitted to government
- Lay-offs at Roche will affect Polish subsidiary
- Apolonia Medical to enter Hungary and three other markets?
- Farmacol disputes Cefarm Bialystok fine
Built-in functionalities make access easier
PMR has designed this online service with the needs of busy executives in mind. Internet access makes market news and information available 24/7 to foreign investment firms thousands of miles outside Poland. Customized newsletter capability allows marketing, insurance and consulting company executives receive emails whenever events occur that affect their main areas of interest. Recently read articles organizes useful information for easy repeat access – especially useful for researchers and analysts. Advanced search enables professionals to narrow down their information category and locate the precise articles and data they need - quickly and easily. All functionalities can be reached at the My PMR Online section of the website.
PMR Online – video presentation:
Learn more about PMR Online news services from the video presentation.To order free trial fill in the form below.
Request more info/demo access
Pharma Poland Online
1 year subscription to internet service providing market news, analyses and analytical articles
Choose your version of this product:
| Language / Licence | Single | 5 Users | Corporate | Global |
| English | 1450€ | 1950€ | 2900€ | 3800€ |
Compare licences
- - for the product preservation: saving the product in the memory of one computer belonging to the client;
- - for multiplying and making the product available: multiplication of the product by production of its copies either by printing or by digitalisation (e.g. on a disc, CD-ROM, DVD, magnetic tape, magneto-optic carrier, print and electronic devices, including electronic paper) for the individual use of one person only, who is indicated by the client during purchasing process.
Any other preservation, multiplication, copying and dissemination etc. which is beyond the scope of this licence is strictly forbidden.
- - for the product preservation: saving the product in the memory of 2 to 5 computers belonging to the organisation indicated by the client while purchasing process; these computers must be located in the same country as the organisation indicated during purchasing process;
- - for multiplying and making the product available: multiplication of the product by production of its copies either by printing or by digitalisation (e.g. on a disc, CD-ROM, DVD, magnetic tape, magneto-optic carrier, print and electronic devices, including electronic paper) for 2 to 5 people who work for the organisation indicated by the client during purchasing process, and who are in the same country as the organisation indicated during purchasing process.
Any other preservation, multiplication, copying and dissemination etc. which is beyond the scope of this licence is strictly forbidden.
- - for the product preservation: saving the product in the memory of an unlimited number of computers belonging to the organisation indicated by the client during purchasing process; these computers must be located in the same country as the organisation indicated during purchasing process;
- - for multiplying and making the product available: multiplication of the product by production of its copies either by printing or by digitalisation (e.g. on a disc, CD-ROM, DVD, magnetic tape, magneto-optic carrier, print and electronic devices, including electronic paper) for an unlimited number of people who work for the organisation indicated by the client during purchasing process, who are in the same country as the organisation indicated during purchasing process.
Any other preservation, multiplication, copying and dissemination etc. which is beyond the scope of this licence is strictly forbidden.
- - for the product preservation: saving the product in the memory of an unlimited number of computers belonging to the organisation indicated by the client during purchasing process; these computers can be located in or outside of the country of the organisation indicated during purchasing process;
- - for multiplying and making the product available: multiplication of the product by production of its copies either by printing or by digitalisation (e.g. on a disc, CD-ROM, DVD, magnetic tape, magneto-optic carrier, print and electronic devices, including electronic paper) for an unlimited number of people who work for the organisation indicated by the client during purchasing process, who are in or outside of the country of the organisation indicated during purchasing process.
Any other preservation, multiplication, copying and dissemination etc. which is beyond the scope of this licence is strictly forbidden.